ACADIA PHARMACEUTICALS INC.
Acadia Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of small molecule drugs for the treatment of central nervous system disorders. The Company maintains two wholly owned subsidiaries: Acadia Pharmaceuticals AB based in Malmo, Sweden and Acadia Pharmaceuticals A/S based in Denmark. The Company is developing a portfolio consisting of four product candidates, including the compound, pimavanserin, which it is developing for three separate neuro... logical and psychiatric indications in collaboration with Biovail Laboratories International SRL (Biovail), a subsidiary of Biovail Corp. The indications are Parkinson's disease psychosis, which is in Phase III development, adjunctive therapy in schizophrenia, and Alzheimer's disease psychosis, for which it is initiating a Phase II feasibility study.
ACADIA PHARMACEUTICALS INC.
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1993-07-16
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.acadia-pharm.com
Total Employee:
501+
Status:
Active
Contact:
(858) 558-2871
Email Addresses:
[email protected]
Total Funding:
811.73 M USD
Technology used in webpage:
SPF Google Tag Manager Domain Not Resolving Global Site Tag Mobile Non Scaleable Content Euro IPv6 Google Maps Google Maps API Cloudflare Hosting
Similar Organizations
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical companyย focused on theย prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2020-08-25 | CerSci Therapeutics | CerSci Therapeutics acquired by Acadia Pharmaceuticals Inc. | 52.5 M USD |
Investors List
National Institute of Neurological Disorders and Stroke
National Institute of Neurological Disorders and Stroke investment in Grant - Acadia Pharmaceuticals Inc.
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Equity - Acadia Pharmaceuticals Inc.
Venrock
Venrock investment in Post-IPO Equity - Acadia Pharmaceuticals Inc.
Nomura International
Nomura International investment in Post-IPO Equity - Acadia Pharmaceuticals Inc.
Oxford Bioscience Partners
Oxford Bioscience Partners investment in Post-IPO Equity - Acadia Pharmaceuticals Inc.
Oxford Bioscience Partners
Oxford Bioscience Partners investment in Post-IPO Equity - Acadia Pharmaceuticals Inc.
ABN AMRO Fund
ABN AMRO Fund investment in Series F - Acadia Pharmaceuticals Inc.
OrbiMed
OrbiMed investment in Series F - Acadia Pharmaceuticals Inc.
LD Pensions
LD Pensions investment in Series F - Acadia Pharmaceuticals Inc.
Federated Investors
Federated Investors investment in Series F - Acadia Pharmaceuticals Inc.
Key Employee Changes
Official Site Inspections
http://www.acadia-pharm.com Semrush global rank: 3.31 M Semrush visits lastest month: 4.9 K
Unable to get host informations!!!